Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Structure-Based Drug Design

6-May-2011
Research & Development

8 - 10 June 2011
Conference
Royal Sonesta Hotel, Boston, Massachusetts, US

8 - 10 June 2011

Conference

Royal Sonesta Hotel, Boston, Massachusetts, US

Rational molecular approaches to targeted therapeutics - from fragments to biology.

Organiser: Cambridge Healthtech Institute

Featured Companies

  • Icrom SRL
  • Nanoform
  • Starlab
  • PCI Pharma Services
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Vectorbuilder Inc
  • Indena
  • Quotient Sciences
  • ProtaGene
  • Actylis – The Partner of Choice
  • DWK Life Sciences

Related Content

High-Content Analysis
High-Content Analysis
2011 World Health Forum
2011 World Health Forum
Diabetes Drug Discovery
Diabetes Drug Discovery
Predictive Functional Human Tissue Models: Moving into the Third Dimension of Drug Discovery and Development
Predictive Functional Human Tissue Models: Moving into the Third Dimension of Drug Discovery and Development
Biomarker Assay Development
Biomarker Assay Development
Bio-IT World Asia
Bio-IT World Asia
Molecular Med Tri-Con 2012
Molecular Med Tri-Con 2012
PEGS Europe
PEGS Europe
PepTalk 2012
PepTalk 2012
Copenhagenomics
Copenhagenomics
Antibody Engineering for Lab Success
Antibody Engineering for Lab Success
Next-Gen Kinase Inhibitors
Next-Gen Kinase Inhibitors
Drug Safety Summit
Drug Safety Summit
Applying Next-Generation Sequencing
Applying Next-Generation Sequencing

This website stores data such as cookies to enable site functionality including analytics and personalization. By using this website, you automatically accept that we use cookies.

  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company